This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.
Objective: To compare the safety and efficacy of clarithromycin and amoxicillin/clavulanic acid in patients with community-acquired pneumonia due to penicillin ...
Phase III study showed sustained proteinuria reduction at one year with favorable safety1 <li /> Fabhalta is the only or ...
19h
MedPage Today on MSNFirst Drug Approved for Ultra-Rare Kidney DiseaseThe FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy ...
StockNews.com upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) from a sell rating to a hold rating in a ...
Cailyn Newman and Sonny Campbell died within eight hours of each other at the Royal Hospital for Children in Glasgow on ...
5d
Sinar Daily on MSNDon't underestimate pneumonia, get vaccinated, experts urgeIndividuals with medical conditions such as diabetes, high blood pressure, heart disease, or chronic lung conditions are also ...
Arizona State Retirement System Buys 125 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Arizona State Retirement System increased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free ...
The two most important measles complications to know about are pneumonia, affecting the lungs, and brain swelling known as ...
A post-mortem examination found bronchial pneumonia and streptococcus G, and gave the cause of death as acute haemorrhagic leukoencephalitis – described as “very rare and usually fatal”, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results